Project Details
Description
PTI-428-06: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect of PTI-428 in Subjects with Cystic Fibrosis
| Status | Finished |
|---|---|
| Effective start/end date | 9/28/18 → 1/1/20 |
Funding
- PROTEOSTASIS THERAPEUTICS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.